pntd.0005645.g003.tif (223.09 kB)
NK cells phenotype in survivors and in fatalities.
figure
posted on 2017-05-30, 17:31 authored by Eleonora Cimini, Domenico Viola, Mar Cabeza-Cabrerizo, Antonella Romanelli, Nicola Tumino, Alessandra Sacchi, Veronica Bordoni, Rita Casetti, Federica Turchi, Federico Martini, Joseph A. Bore, Fara Raymond Koundouno, Sophie Duraffour, Janine Michel, Tobias Holm, Elsa Gayle Zekeng, Lauren Cowley, Isabel Garcia Dorival, Juliane Doerrbecker, Nicole Hetzelt, Jonathan H. J. Baum, Jasmine Portmann, Roman Wölfel, Martin Gabriel, Osvaldo Miranda, Graciliano Díaz, José E. Díaz, Yoel A. Fleites, Carlos A. Piñeiro, Carlos M. Castro, Lamine Koivogui, N’Faly Magassouba, Boubacar Diallo, Paula Ruibal, Lisa Oestereich, David M. Wozniak, Anja Lüdtke, Beate Becker-Ziaja, Maria R. Capobianchi, Giuseppe Ippolito, Miles W. Carroll, Stephan Günther, Antonino Di Caro, César Muñoz-Fontela, Chiara AgratiThe frequency of CD56dim NK cells expressing CD69pos (A), NKp46pos (B) and CD158a pos (C) was analyzed in HD (n = 14), EBOV-survivors (n = 8) and EBOV-fatalities (n = 6). The frequency of CD56neg NK cells expressing CD69pos (D), NKp46pos (E) and CD158apos (F) was analyzed in HD (n = 14), EBOV-survivors (n = 8) and EBOV-fatalities (n = 6). Statistical analysis was performed by using Mann Whitney test and differences were considered significant with a p<0.05, and highlighted with an asterisk. *: p<0.05; **: p<0.01; ***: p<0.001.
